Navigation Links
Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
Date:10/30/2007

2007 2006

$ $

-------------------------------------------------------------------------

ASSETS

Current

Cash and cash equivalents 3,326,374 3,491,511

Short-term investments 24,865,090 24,122,237

Accounts receivable 36,637 84,003

Prepaid expenses 413,811 638,540

-------------------------------------------------------------------------

28,641,912 28,336,291

Property and equipment 169,226 149,596

Intellectual property 5,085,755 5,079,805

-------------------------------------------------------------------------

33,896,893 33,565,692

-------------------------------------------------------------------------

-------------------------------------------------------------------------

LIABILITIES AND SHAREHOLDERS' EQUITY

Current

Accounts payable and accrued liabilities 2,298,064 2,616,421

-------------------------------------------------------------------------

Alberta Heritage Foundation loan - 150,000

-------------------------------------------------------------------------

Shareholders' equity

Share capital

Authorized: unlimited number of common shares

Issued: 41,120,748 (December 31, 2006 -

36,520,748) 92,708,665 83,083,271

Warrants 6,654,740 4,216,740

Contributed surplus 8,672,204 8,529,326

Deficit (76,436,7
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion
Post Your Comments:
*Name:
*Comment:
*Email: